Domestic pharmaceutical companies develop salt-modified drugs of Viread in series

Published: 2016-02-05 14:41:12

Updated: 2016-02-05 14:41:12

Dong-A ST, Chong Kun Dang, CJ HealthCare and JW Pharmaceutical are developing incrementally modified drugs of Viread(generic name: tenofovir), a chronic hepatitis B treatment.

The pharmaceutical companies have field a trial for (defensive) confirmation of the scope of the right related to the Viread’s ‘Nucleotide-similar Composition and Synthesis Method’ and won the case.

The Viread’s substan...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.